Pediatric Craniosynostosis Treatment Market Size was valued at USD 5.32 Billion in 2023. The Global Pediatric Craniosynostosis Treatment industry is projected to grow from USD 5.65 Billion in 2024 to USD 12.65 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.32% during the forecast period (2024 - 2032).
Craniosynostosis is a common cranial malformation resulting from the premature fusion of cranial sutures and changing of the skull’s growth pattern. Generally, craniosynostosis is classified into two broad categories, namely, syndromic and nonsyndromic. Syndromic craniosynostosis accounts for approximately 25% of reported cases, and results from more than 180 identified monogenic syndromes.
According to the study published in the Journal of Cranio-Maxillofacial Surgery in 2016, it was found that the prevalence of craniosynostosis is nearly 3.1 to 6.4 in 10.000 live births, which is reportedly rising. On considering the historical data, it is found that the prevalence of craniosynostosis, specially, sagittal and metopic suture synostosis, has risen significantly from 1997 until 2013. It is also reported that Sagittal synostosis was the most common type among all i.e. 44%. The Sagittal synostosis occurs predominantly in males.
Notably, rising technological advancements is the key factor driving the pediatric craniosynostosis treatment market. It has been observed that most of population has been giving preference to minimally invasive surgery for the therapeutic purpose. The major appealing aspects about opting minimally invasive procedure are short hospital stay, less pain, small or no incision, quick recovery time, and reduction in blood loss.
Various other push factors such as increasing awareness among people, escalating prevalence of craniosynostosis, increasing government assistance, amendments in regulatory framework, and rising funding and reimbursement are continuously contributing to the growth of the pediatric craniosynostosis treatment market.
Despite these drivers, there are some issues associated with the pediatric craniosynostosis treatment market. Lack of skilled physicians and endoscopists, challenges in research and development, risk of infections caused by endoscopes, high cost of treatment, and poor healthcare system in low and middle-income countries may hamper the market growth.
Intended Audience
The pediatric craniosynostosis treatment market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, the market is segmented into single-suture synostosis, double-suture synostosis, and complex multisuture synostosis. The single-suture synostosis is further segmented into sagittal suture synostosis, coronal suture synostosis, metopic suture synostosis, and lambdoidal suture synostosis. The double-suture synostosis is further segmented into bicoronal, bilambdoid and sagittal plus metopic.
On the basis of diagnosis, the market is classified into physical examination, genetic testing, and imaging studies.
On the basis of treatment, the market is classified as stereotactic image guided endoscopic craniosynostosis repair, standard craniosynostosis surgery, baby helmet therapy, and others. The stereotactic image guided endoscopic craniosynostosis repair is further segmented into real-time stereotactic-endoscopic craniectomy and endoscopic strip sagittal craniectomy. The standard craniosynostosis surgery is further segmented into strip sagittal craniectomy, Frontal-Orbital Advancement (FOA), and Frontal-Occipital Reversal (FOR).
On the basis of end-user, the market is segmented into hospital, clinics, diagnostic centers, and others.
The Americas dominate the pediatric craniosynostosis treatment market owing to the rising awareness about disease and high healthcare expenditure. The total health expenditure in the United States was reported to be USD 3.2 trillion, suggested by the Centers for Disease Control and Prevention (CDC). Whereas, hospital care accounted for a share of 32.3%, in 2015.
Europe holds the second position in the pediatric craniosynostosis treatment market. It is expected that the support provided by the government and private associations for research & development and amendments in reimbursement policies in healthcare are likely to promote the market of the European region. The rising prevalence of craniosynostosis in the European region is also expected to boost the market growth. The prevalence of craniosynostosis is found to be around 7.2 per 10.000 live born children in the Netherlands, suggested by the Journal of Cranio-Maxillofacial Surgery in 2016.
Asia Pacific is the fastest growing region in the pediatric craniosynostosis treatment market owing to the developing healthcare technology. Healthcare expenditure is also found to be escalating in various Asian countries.
The Middle East & Africa holds the lowest market share in the pediatric craniosynostosis treatment market due to lack of technical knowledge and poor medical facilities.
Some of the key players in the pediatric craniosynostosis treatment market are:
| Report Attribute/Metric | Details |
| Market Size | USD 12.65 Billion (By 2032) |
| CAGR | 6.32% |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, diagnosis, treatment, and end-user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Arthrex Inc., B. Braun Melsungen AG, Cogentix Medical, CONMED Corporation, Cook Medical, Frontier Healthcare, Fujifilm Holdings Corporation, Hoya Corporation, Johnson & Johnson Services, Inc., KARL STORZ GmbH & Co. KG, Medtronic Plc, Minntech Corporation, Olympus Corporation, Pentax Medical, Richard Wolf GmbH, Siemens Healthcare, Smith & Nephew Plc, STERIS Corporation, Stryker Corporation, US Endoscopy Group, and others. |
| Key Market Opportunities | Various other push factors such as increasing awareness among people, escalating prevalence of craniosynostosis, |
| Key Market Drivers | Rising funding and reimbursement are continuously contributing to the growth of the pediatric craniosynostosis treatment market. |
Frequently Asked Questions (FAQ) :
Craniosynostosis is a common cranial malformation resulting from the premature fusion of cranial sutures and changing of the skull’s growth pattern.
The Pediatric Craniosynostosis Market is expected to exhibit a strong 6.32% CAGR over the forecast period from 2024 to 2032.
Increasing availability of minimally invasive surgeries for fixing the problem is the major driver for the Pediatric Craniosynostosis Market.
The Americas dominate the global Pediatric Craniosynostosis Market due to the widespread awareness among parents.
Leading players in the Pediatric Craniosynostosis Market include Arthrex, Cogentix Medical, and Fujifilm Holding, among others.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
